Summary
Although primary treatment of medulloblastoma is now successful in a high percentage of patients, its secondary manifestations still bear a poor prognosis. Thorough studies of secondary manifestations are therefore pivotal to plan therapeutic approaches for the long-term management of medulloblastoma. Here we describe the incidence of secondary tumour manifestations in 66 patients of a single centre who underwent surgery for medulloblastoma between 1975 and 1990. No patient was excluded due to a poor postoperative course. Thirty-five patients showed evidence of secondary tumour growth. Of these, 17 suffered from local recurrence, and 27 developed metastastatic disease. The median latencies for secondary manifestations were 25 months for local recurrence (n = 17), 11 months for spinal metastases (n = 10), 15 months for supratentorial metastases (n = 8), 8 months for subleptomeningeal dissemination (n = 6), and 23 months for systemic metastases (n = 8). Two patients developed primary metastatic spread to the posterior fossa. Of 8 patients with supratentorial metastases, 6 developed fronto-basal lesions. In our patients, 89% of secondary lesions occurred within less than 3 years after primary diagnosis. 85% of patients with extra-axial tumour spread had been treated with a permanent shunt. Radical tumour resection and radiotherapy with 30 Gy to the neuraxis and 20 Gy boost to the posterior fossa was an important prognostic factor in this series. Patients with additional chemotherapy did not benefit significantly from this treatment. We conclude that optimal management of the primary lesions should aim at (i) total resection, (ii) avoid permanent shunting, and (iii) completion of the radiotherapy with inclusion of the medial frontobasal cisterns in the radiotherapeutic regimen. Our analysis suggests that adequate postoperative screening programmes should consist of 3-monthly scans of the neuraxis in the first three postoperative years and 6-monthly scans thereafter.
Similar content being viewed by others
References
Allen JC (1986) Systemic metastases from medulloblastoma: respone to chemotherapy. In: Zeltzer OM, Pochedly C (eds) Medulloblastomas in children. Praeger, New York
Barden RL, Lewey FH (1949) Metastasizing cerebellar tumors. J Neurosurg 6: 439–449
Barnwell SC, Edwards MS (1986) Spinal intramedullary spread of medulloblastoma. J Neurosurg 65: 253–255
Berger MS, Baumeister B, Geyer R, Milstein J, Kanev PM, LeRoux PD (1991) The risks of metastases from shunting in children with primary central nervous system tumors. J Neurosurg 74: 872–877
Brutschin P, Culver GJ (1973) Extracranial metastases from medulloblastoma. Radiology 107: 359–362
Chamberlain MC, Silver P, Edwards MSB, Levin BA (1988) Treatment of extraneural metastatic medulloblastoma with a combination of cyclophosphamide, adriamycin and vincristine. Neurosurgery 23: 476–479
Choux M, Lena G (1982) Le medulloblastome. Neurochirurgie 28 [Suppll]: 229 pp
Constans JP, Donzelli R, Signorelli CD, Spaziante R, Maiuri F, de Devitis E (1984) Medulloblastomas with metastases outside the nervous system. Acta Neurol 6: 25–31
Culley JD, Berger MS, Shaw D, Geyer R (1994) An analysis of factors influencing the need for ventriculoperitoneal shunts after posterior fossa surgery in children. Neurosurgery 34: 402–407
Deutsch M, Reigel DH (1980) The value of myelography in the management of childhood medulloblastoma. Cancer 45: 2194–2197
Donnal J, Halperin EC, Friedman HS, Boyko OB (1992) Subfrontal recurrence of medulloblastoma. AJNR 13: 1617–1618
Edwards MSB (1989) Medulloblastoma and PNET's of posterior fossa. In: Mc Laurin RLet al (eds) Pediatric neurosurgery. Saunders, Philadelphia, pp 347–356
Epstein F, Murali R (1978) Pediatric posterior fossa tumors: hazards of the preoperative shunt. Neurosurgery 3: 348–350
Evans AE, Jenkin DT, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin S, Hammond GD (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 72: 572–582
George RE, Laurent JP, McCluggage CW, Cheek WR (1986) Spinal metastases in primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa: evaluation with CT, myelography and correlation with patient age and tumor differentiation. Pediatr Neurosci 12: 157–160
Guthkelch M (1983) Filtered shunts in treatment of medulloblastomas? J Neurosurg 59: 364
Hardy DG, Hope-Stone HF, McKenzie CG, Scholtz CL (1978) Recurrence of medulloblastoma after homogeneous field radiation. J Neurosurg 49: 434–440
Hoffman HJ, Hendrick EB, Humphreys RP (1976) Metastasis via ventriculoperitoneal shunt in patients with medulloblastoma. J Neurosurg 44: 562–566
Jaksche H, Wöckel W, Wernert M (1988) Primary spinal medulloblastomas. Neurosurg Rev 11: 259–265
Jamjoon ZA, Jamjoon AB, Sulaiman AH (1993) Systemic metastases through ventriculoperitoneal shunt: report of a case and critical analysis of the literature. Surg Neurol 40: 403–410
Jereb B, Sundaresan N, Horten B, Reid N, Galicien JH (1981) Supratentorial recurrences in medulloblastoma. Cancer 47: 806–809
Jereb B, Reid A, Ahuja RK (1982) Patterns of failure in patients with medulloblastoma. Cancer 50: 2941–2947
Kessler LA, Dugan P, Concannon JP (1975) Systemic metastases of medulloblastoma promoted by shunting. Surg Neurol 3: 147–152
Kleinmann GM, Hochberg FH, Richardson EP (1981) Systemic metastases from medulloblastoma: report of two cases and review of the literature. Cancer 48: 2296–2309
Lapras C, Patet JD, Mottolese C, Vitale G (1987) Cerebellar astrocytomas in children. Prog Exp Tumor Res 30: 128–134
Lassman P, Pearce GW, Banna M, Jones RD (1969) Vincristine sulphate in the treatment of skeletal metastases from cerebellar medulloblastoma. J Neurosurg 30: 42–49
Lefkowitz I, Packer RJ, Ryan SG, Shah N, Alavi J, Rorke LB, Sutton LN, Schut L (1988) Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Cancer 62: 826–830
Levin VA, Vestinys PS, Edwards MSB, Wara WM, Fulton D, Barger G, Seager M, Wilson CB (1983) Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma. Cancer 51: 1364–1370
Lowery GS, Kimball JC, Patterson RB, Raben M (1982) Extraneural metastases from cerebellar medulloblastoma. Am J Pediatr Hematol Oncol 4: 259–262
Mahoney Jr DH, Steuber CP, Sandbach JF, Fernbach DJ (1986) Extraneural metastases from medulloblastoma: longterm survival after sequentially scheduled chemotherapy and radiotherapy. Med Pediatr Oncol 14: 329–331
McComb JG, Davis RL, Isaacs H, Landing BH (1980) Medulloblastoma presenting as neck tumors in 2 infants. Ann Neurol 7: 113–117
McComb JG, Davis RL, Isaacs H (1981) Extraneural metastatic medulloblastoma during childhood. Neurosurgery 9: 548–551
Megele R, Gruß P, Bührmann K (1989) Das extrakraniell metastasierende maligne Gliomiatrogen? Neurochirurgia 32: 157–159
Mooney C, Souhami R, Pritchard J (1983) Recurrent medulloblastoma. Canc Chemother Pharmacol 10: 135–136
Nishio S, Fukui M, Takeshita I, Nakagaki H, Kitamura K, Jingu K (1986) Recurrent medulloblastoma in children. Neurol Med Chir 26: 19–25
Packer RJ, Sutton LN, D'Angio G, Evans AE, Schut L (1986) Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma. Pediatr Neurosci 12: 272–282
Palacios E, Shannon M, Fine M (1979) Unusual metastases of medulloblastoma. Case report. Neuroradiology 17: 219–222
Papo I, Caruselli G, Luongo A (1982) External ventricular drainage in the management of posterior fossa tumors in children and adolescents. Neurosurgery 10: 13–15
Park TS, Hoffman HJ, Hendrick EB, Humphreys RP, Becker LE (1983) Medulloblastoma: clinical presentation and management. J Neurosurg 58: 543–552
Rappaport ZH, Shalit MN (1989) Perioperative external ventricular drainage in obstructive hydrocephalus secondary to infratentorial brain tumors. Acta Neurochir (Wien) 96: 118–121
Rutka JT, Hoffman HJ (1991) A Critical review of medulloblastoma: from a difficult past to a promising future. Neurosurg Quart 1: 54–78
Shen W, Yang C (1988) Multifocal cerebellar medulloblastoma: CT findings. J Comp Assist Tomography 12: 894
Stanley P, Suminski N (1988) The incidence and distribution of spinal metastases in children with posterior forssa medulloblastoma. Am J Pediatr Hematol Oncol 10: 283–287
Tait DM, Thornton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the international society of paediatric oncology (SIOP I). Eur J Cancer 26: 464–469
Tomita T, McLone DG (1983) Spontaneous seeding of medulloblastoma: results of cerebrospinal fluid cytology and arachnoid biopsy from the cisterna magna. Neurosurgery 12: 265–267
Sure U, Berghorn WJ, Bertalanffy H, Wakabayashi T, Yoshida J, Sugita K, Seeger W (1995) Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir (Wien) 32: 59–65
Torres CT, Rebsamen S, Silber JH, Sutton LN, Bilaniuk LT, Zimmerman RA, Goldwein JW, Phillips PC, Lange BJ (1994) Surveillance scanning of children with medulloblastoma. N Engl J Med 330: 892–895
Uozumi A, Yamaura A, Makino H, Miyoshi T, Arimizu M (1990) A newly designed radiation port for medulloblastoma to prevent metastasis to the cribriform plate region. Childs Nerv Syst 6: 451–456
Voth D, Schwartz M, Huwel N (1981) Shunt therapy in medulloblastoma? Acta Neurochir (Wien) 56: 278
Wagner W, Böttcher HD, Korinthenberg R, Schadel A (1985) Extraneurale Medulloblastommetastase nach nicht operiertem Medulloblastom. Klin Pädiatr 197: 135–137
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sure, U., Bertalanffy, H., Isenmann, S. et al. Secondary manifestation of medulloblastoma: Metastases and local recurrences in 66 patients. Acta neurochir 136, 117–126 (1995). https://doi.org/10.1007/BF01410612
Issue Date:
DOI: https://doi.org/10.1007/BF01410612